ArticleHistochemistry and cell biology2025
Development of optimized differentiation media for murine bone marrow multipotent mesenchymal stromal cells.
Article in Histochemistry and cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Here, we aimed to define adipogenic, osteogenic, and chondrogenic media for the differentiation of murine mesenchymal stromal cells (MSCs). We used differentiation media formulations optimized for use with human bone marrow-derived MSCs as the starting medium and modified the contents of the differentiation media by testing the differentiation potential of the Op9 stromal cell line, a murine enhanced green fluorescent protein transgenic (eGFP+) bone marrow-derived MSC line, and freshly isolated murine BALB/c bone marrow MSCs. We optimized the media through assessment of (immuno)histological staining and assessment of adipogenic, osteogenic, and chondrogenic differentiation-specific gene expression. Adipogenic differentiation was found to improve in a high-glucose setting, whereas chondrogenic differentiation increased in the presence of insulin-like growth factor-1 (IGF-1). Modifications made to the osteogenic media did not further improve the differentiation capacity of the murine MSCs. In conclusion, using minor changes to existing protocols, we found it possible to increase the overall efficacy of murine MSC differentiation. These modified protocols will further aid in a better understanding of the true differentiation capacity of these cells, and improvement of tissue engineering protocols.
Indexed as
Identifiers
40828429What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.